Oncostatin M 抗体

Zhu, Che, Liao, Wang, Wang, Chen, Wang, Dai, Wan: "Oncostatin M activates STAT3 to promote endometrial cancer invasion and angiogenesis." in: Oncology reports, Vol. 34, Issue 1, pp. 129-38, (2015) (PubMed).

Kang, Kim, Jang, Park, Lee, Kim: "22q11-q13 as a hot spot for prediction of disease-free survival in bile duct cancer: integrative analysis of copy number variations." in: Cancer genetics, Vol. 207, Issue 3, pp. 57-69, (2014) (PubMed).

Guo, Chen, Shi, Wang, Chen, Diao, Hu, Yu, Qian, Guo: "Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition." in: Oncogene, Vol. 32, Issue 45, pp. 5272-82, (2013) (PubMed).

Ohsaka, Hirota-Komatsu, Shibata, Ezaki, Shinohara, Yoshida: "Specific association of increased vascular endothelial growth factor expression and its receptors with macrophage differentiation of HL-60 leukemia cells." in: Biochemical and biophysical research communications, Vol. 368, Issue 3, pp. 543-9, (2008) (PubMed).

He, Gong, Smith, Ip: "The N-terminal cytokine binding domain of LIFR is required for CNTF binding and signaling." in: FEBS letters, Vol. 579, Issue 20, pp. 4317-23, (2005) (PubMed).

Hurst, McLoughlin, Monslow, Owens, Morgan, Fuller, Topley, Jones: "Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 169, Issue 9, pp. 5244-51, (2002) (PubMed).

Modur, Feldhaus, Weyrich, Jicha, Prescott, Zimmerman, McIntyre: "Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules." in: The Journal of clinical investigation, Vol. 100, Issue 1, pp. 158-68, (1997) (PubMed).